Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Medical devices / Therapeutic and rehabilitation devices / Dialysis machines, consumables and home dialysis systems

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Dialysis machines, consumables and home dialysis systems

Dialysis providers, hospitals and home dialysis programmes buying haemodialysis machines, peritoneal dialysis cyclers, dialysers, tubing and related consumables for in-centre and home-based renal replacement therapy.

Market size
—
Not sized yet
Growth
—
CAGR
Attractiveness
85 /100
for B2B sellers
Evidence
not sized
3 sources · no estimate
Level
Niche
Segmented by
Customer type
Buyers
Dialysis providers and renal care organisations (plus hospital dialysis units)
Buying centre
Dialysis provider clinical and operations leadership with procurement, biomedical engineering and, for home programmes, patient training and payer-contract teams
Buying triggers
  • Growth of the dialysis population from diabetes, hypertension and ageing
  • Home dialysis adoption targets and value-based renal care contracts
  • Replacement of ageing machine fleets and upgrade to remote monitoring
  • Reimbursement reform favouring home over in-centre treatment
Scores (1–5)
Pain intensity5
Purchasing power5
Reachability3
Growth4

How this was sized

Not sized yet

Bottom-up: global medical device market ~USD 580-640bn in 2026 [4]; renal/dialysis devices and consumables are commonly estimated at roughly 8-10% of the device market, implying ~USD 50-65bn globally, of which machines ~35-40% (USD 18-26bn) and consumables ~60-65% (USD 32-42bn). Low confidence: the segment share is an assumption and no source in the set sizes dialysis devices. Sources [4][6][9] used only for the total device market anchor.

Alongside it in Therapeutic and rehabilitation devices

// Sell into Dialysis machines, consumables and home dialysis systems

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.